Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and ...

The National Institutes of Health awarded researchers at the University of North Carolina at Chapel Hill a three-year, $1.8 million grant for the development of an implantable drug delivery system for ...

Researchers have developed a wireless implantable drug delivery system that enables anticancer drugs to penetrate deep into solid tumors—without harming surrounding healthy tissue. The ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Sustained delivery devices are transforming the ...

Researchers at the University of North Carolina at Chapel Hill have received a three-year, $1.8 million grant from the National Institutes of Health to develop a new implantable drug delivery system ...

MicroCHIPS, an MIT-affiliated developer of implantable drug delivery devices and biosensors, found their programmable implant was able to deliver the osteoporosis drug teriparatide at scheduled ...

The FDA approved Medasys’ Prometra programmable implantable drug pump for the intraspinal delivery of INFUMORPH, a preservative-free morphine sulfate sterile solution, for the management of pain, ...

Intrathecal drug delivery involves administering analgesic medications directly into the cerebrospinal fluid, thereby achieving targeted pain relief while minimising systemic side effects. This method ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Generic drug giant makes equity investment in Microchips ...

Researchers from Seoul National University (Prof. Seung-Kyun Kang), the Korea Institute of Science and Technology, KIST (Dr. Hyojin Lee), Kwangwoon University (Prof. Jeonghyun Kim), and Gyeongsang ...